Supernus, Inc. (NasdaqGS: SUPN)
Health Care · Pharmaceuticals · US
$29.72
+1.78% today · -5.3% 1Y
Supernus, Inc. (NasdaqGS: SUPN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.17B and employs 833 people.
Over the last twelve months the share price has lost 5.3%, trading between 25.92 and 42.81.
Tweenvest scores Supernus, Inc. across four factors: quality 51/100, value 50/100, growth 62/100. Its strongest factor is growth.
SUPN price history
Key figures
- Market cap
- $6.17B
- Revenue (TTM)
- $1.37B
- P/E
- 8.36
- EPS
- 3.58
- Dividend yield
- —
- Beta (5Y)
- 1.13
- 52-week high
- $42.81
- 52-week low
- $25.92
- Avg volume (3M)
- —
- Shares outstanding
- 207.72M
- Employees
- 833
- Next earnings
- —
About Supernus, Inc.
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
- ISIN
- US45579U1097
- Founded
- 2014
- Listed since
- Dec 29, 2014
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alkem Laboratories LimitedNSEI: ALKEM | $6.68B | Rs5,222.50 | +0.92% |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.SZSE: 000999 | $6.59B | CN¥26.40 | -0.04% |
| Apotex Health Corp.TSX: APTX | $6.45B | CA$40.28 | +2.13% |
| Ligand Pharmaceuticals IncorporatedNasdaqGM: LGND | $6.33B | $316.27 | -0.18% |
| Abbott India LimitedBSE: 500488 | $5.97B | Rs26,413.50 | -0.71% |
| Gland Pharma LimitedNSEI: GLAND | $5.85B | Rs3,334.10 | +0.77% |
| Sumitomo Pharma Co., Ltd.TSE: 4506 | $5.66B | ¥2,018.00 | -0.49% |
| Veradermics, IncorporatedNYSE: MANE | $5.47B | $129.66 | -4.16% |